Orthophosphate increases the efficiency of slow muscle-myosin isoform in the presence of omecamtiv mecarbil

Omecamtiv mecarbil is a small molecule effector under clinical trial for the treatment of systolic heart failure. Here the authors define the molecular mechanisms of its inotropic action and find it can increase the efficiency of contraction in muscle fibres when the orthophosphate concentration ris...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Serena Governali, Marco Caremani, Cristina Gallart, Irene Pertici, Ger Stienen, Gabriella Piazzesi, Coen Ottenheijm, Vincenzo Lombardi, Marco Linari
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
Q
Acceso en línea:https://doaj.org/article/a1356051549946cab751e8490d8aee60
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares